🟢 Health ETF (ARKG) is trading 4.66% up today as post-Fed recovery lifts genomics

ARKG is trading at $50.08 (+4.66%) on September 17, 2026, significantly outperforming its $47.85 September 16 close, amid a broad risk-on recovery after the Federal Reserve’s September 16 rate hike removed immediate policy uncertainty.

• Easing Treasury yields supported high-growth biotechnology and genomics stocks.
• The broader market is advancing, with the S&P 500 up 0.91% and Nasdaq up 1.23%, reinforcing sector-wide momentum.
• The GSK–Chimagen transaction adds positive biotech sentiment, but is not a dominant ARKG-specific driver.